Four Thought Financial Partners, LLC Merck & Co., Inc. Transaction History

Four Thought Financial Partners, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$113.24 - $131.95 $4,982 - $5,805	-44 Reduced 0.8%	5,442 $718 Million
Q4 2023 Feb 06, 2024	SELL	$100.18 - $109.02 $121,518 - $132,241	-1,213 Reduced 18.11%	5,486 $598 Million
Q3 2023 Nov 13, 2023	SELL	$102.95 - $114.33 $151,027 - $167,722	-1,467 Reduced 17.96%	6,699 $690 Million
Q2 2023 Aug 11, 2023	SELL	$108.61 - $118.38 $9,340 - $10,180	-86 Reduced 1.04%	8,166 $942 Million
Q1 2023 May 04, 2023	BUY	$102.94 - $114.86 $36,749 - $41,005	357 Added 4.52%	8,252 $878 Million
Q4 2022 Feb 07, 2023	BUY	$87.44 - $112.11 $690,338 - $885,108	7,895 New	7,895 $876 Million

3,825

1.91B

13.4M

10.7M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $300B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of Four Thought Financial Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Four Thought Financial Partners, LLC with notifications on news.